Joseph Kauer

17PUBLICATIONS
98CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 13, 2025
Acquired and Selected: Tracking Antigen Escape during T Cell-Redirecting Therapies in Multiple Myeloma.

Joseph Kauer, Niels Weinhold, Marc S Raab

|Apr 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.

Jan H Frenking, Xiang Zhou, Kai Rejeski

|Dec 11, 2024
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff

|Sep 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML.

Julia M Unglaub, Richard F Schlenk, Jan Moritz Middeke

|Apr 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta

|Apr 13, 2024
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts.

Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann

Pageof 3

Frequent Collaborators

5 joint publications

Helmut R Salih

4 joint publications

Melanie Märklin

3 joint publications

Latifa Zekri

2 joint publications

Jonas S Heitmann